Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Willis

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Potential role of fructose on human colon DNA methylation in racial disparities observed for colorectal cancer riskMatthew A Devall, Stephen Eaton, Gaizun Hu, et al.
The American Journal of Clinical Nutrition|January 9, 2025
Association between dietary fructose and human colon DNA methylation: implication for racial disparities in colorectal cancer risk using a cross-sectional studyMatthew A Devall, Stephen Eaton, Gaizun Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2003
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancersHui Li, Lois Myeroff, Dominic Smiraglia, et al.
Genes, Chromosomes & Cancer|February 4, 2012
The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesisRom S Leidner, Lakshmeswari Ravi, Patrick Leahy, et al.
Cancer Research|April 3, 2003
PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancerElaine B Brunschwig, Keith Wilson, David Mack, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2004
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancersMin Yan, Ronald M Rerko, Petra Platzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2006
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesisSeung-Jae Myung, Ronald M Rerko, Min Yan, et al.
Oncotarget|October 6, 2015
Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survivalStephen P Fink, Lois L Myeroff, Revital Kariv, et al.
Gastroenterology|February 13, 2013
Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polypsJoanne Ngeow, Brandie Heald, Lisa A Rybicki, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumorsMin Yan, Seung-Jae Myung, Stephen P Fink, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Potential role of fructose on human colon DNA methylation in racial disparities observed for colorectal cancer riskMatthew A Devall, Stephen Eaton, Gaizun Hu, et al.
The American Journal of Clinical Nutrition|January 9, 2025
Association between dietary fructose and human colon DNA methylation: implication for racial disparities in colorectal cancer risk using a cross-sectional studyMatthew A Devall, Stephen Eaton, Gaizun Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2003
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancersHui Li, Lois Myeroff, Dominic Smiraglia, et al.
Genes, Chromosomes & Cancer|February 4, 2012
The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesisRom S Leidner, Lakshmeswari Ravi, Patrick Leahy, et al.
Cancer Research|April 3, 2003
PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancerElaine B Brunschwig, Keith Wilson, David Mack, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2004
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancersMin Yan, Ronald M Rerko, Petra Platzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2006
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesisSeung-Jae Myung, Ronald M Rerko, Min Yan, et al.
Oncotarget|October 6, 2015
Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survivalStephen P Fink, Lois L Myeroff, Revital Kariv, et al.
Gastroenterology|February 13, 2013
Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polypsJoanne Ngeow, Brandie Heald, Lisa A Rybicki, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumorsMin Yan, Seung-Jae Myung, Stephen P Fink, et al.
Pageof 9